Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer

Histopathology
C J WittonJ M S Bartlett

Abstract

Inflammation and hormonal signalling induce cyclooxygenase 2 (COX2) expression in solid tumours. COX2 expression is linked to neovascularization and tumour growth. HER2 modulates colorectal cancer COX2 expression. We investigated interactions between COX2 and HER1-4 in breast cancer. COX2 expression was localized to epithelial cells with 21.2% of cases expressing higher levels than normal epithelium. Elevated COX2 expression was not associated with size, grade, high Nottingham prognostic index (NPI) or oestrogen receptor (ER) negativity. No association was observed between COX2 and HER1-4 expression. High COX2 expression was associated with reduced disease-free survival (P = 0.03) and disease-related survival in ER-negative (P = 0.046) but not ER-positive disease (P = 0.835). HER1, 2, 3 and 4 are not associated with high breast tumour COX2 expression. COX2 is frequently expressed in breast carcinoma cells and adjacent epithelium. COX2 may be an important factor in promoting tumour progression in ER-negative tumours and a potential drug target in breast tumours.

References

Jul 17, 1996·Journal of the National Cancer Institute·K M EganG A Colditz
Mar 1, 1996·Epidemiology·R E HarrisW B Farrar
Apr 1, 1998·Journal of the National Cancer Institute·D HwangE Levine
Feb 2, 1999·Oncogene·R VadlamudiR Kumar
Jan 12, 2000·Oncogene·C S WilliamsR N DuBois
Jul 31, 2001·International Journal of Cancer. Journal International Du Cancer·J G RozicP K Lala
Jul 31, 2001·International Journal of Cancer. Journal International Du Cancer·N KunduA M Fulton
Feb 19, 2002·The Journal of Steroid Biochemistry and Molecular Biology·A M BrodieJ H Thijssen
Mar 19, 2002·The Journal of Steroid Biochemistry and Molecular Biology·Jeanette A RichardsRobert W Brueggemeier
Mar 20, 2002·The Journal of Biological Chemistry·Kotha SubbaramaiahAndrew J Dannenberg
Mar 14, 2003·The Journal of Pathology·John BartlettTim Cooke
Apr 3, 2003·American Journal of Physiology. Renal Physiology·Hongyu ZhaoDavid M Cohen
Jul 8, 2003·The Journal of Pathology·Caroline J WittonJohn M S Bartlett

❮ Previous
Next ❯

Citations

Sep 1, 2005·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P CejasM González-Barón
Aug 19, 2007·Archives of Gynecology and Obstetrics·Lars-Christian HornKarl Bilek
Sep 1, 2007·Diseases of the Colon and Rectum·Valeria BarresiGaetano Barresi
May 3, 2011·Breast Cancer Research and Treatment·Hee Sung KimDong-Young Noh
Jul 6, 2011·Breast Cancer Research and Treatment·Michelle D HolmesRulla M Tamimi
Jan 31, 2012·Breast Cancer Research and Treatment·Byeong-Woo ParkKyong Sik Lee
Oct 18, 2011·Cancer Metastasis Reviews·Claus Schneider, Ambra Pozzi
Apr 1, 2010·Medical Oncology·Nagehan Ozdemir BarısıkNimet Karadayı
Jul 30, 2010·Medical Oncology·Erhan AraratKadri Altundag
Aug 28, 2007·Applied Immunohistochemistry & Molecular Morphology : AIMM·Aziza NassarCynthia Cohen
Mar 26, 2011·Annals of Surgical Oncology·Yasunori AkutsuHisahiro Matsubara
Sep 3, 2010·The Tohoku Journal of Experimental Medicine·Hui CaoShao-lin Li
Sep 17, 2008·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Zuzana KrcovaZdenek Kolar
Mar 29, 2014·Indian Journal of Surgical Oncology·Debarshi JanaSyamsundar Mandal
Apr 2, 2010·Breast Cancer Research and Treatment·Johanna G H van NesJohn M S Bartlett
Aug 10, 2005·The Journal of Pathology·Tove KirkegaardJohn M S Bartlett
Sep 14, 2010·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Ambra Pozzi, Roy Zent
Dec 15, 2005·The Journal of Pathology·Sanjana MehrotraSunil Badve
Jun 29, 2011·The Journal of Pathology·Chia-Ing JanJeng-Fan Lo
Mar 7, 2014·International Journal of Cancer. Journal International Du Cancer·Andrea MarkkulaHelena Jernström
Jun 27, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·K ParkJ-Y Kim
Mar 5, 2011·Pathology, Research and Practice·Ibrahim Metin ÇirişFatma Nilgün Kapucuoğlu
Oct 31, 2012·Korean Journal of Pathology·Ji Won LeeKyung Chul Moon
Sep 16, 2016·International Journal of Cancer. Journal International Du Cancer·Maria SimonssonHelena Jernström
Sep 18, 2009·Virchows Archiv : an International Journal of Pathology·Sara Jonmarker JarajLars Egevad
Aug 30, 2005·Laboratory Investigation; a Journal of Technical Methods and Pathology·Ana M TariWilliam F Symmans
Dec 24, 2005·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·L NakopoulouA Keramopoulos
Jun 12, 2010·Expert Opinion on Therapeutic Targets·Antonella MigliettaClaudia Bocca
Jun 24, 2017·Breast Cancer Research and Treatment·Brandi L ClarkLandry K Kamdem

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
K ParkJ-Y Kim
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
P A CanneyJ Curto
© 2022 Meta ULC. All rights reserved